Propanc raises $1M to start crypto treasury aimed at funding cancer therapy

Propanc raises $1M to start crypto treasury aimed at funding cancer therapy

Crypto treasury is at the center of Propanc’s latest move — an initial $1M from Hexstone that could expand to $100M. Curious how a biotech mixes digital assets with drug development and what risks that brings? Keep reading.

Deal terms, funding plan and how the convertible preferred placement works

Crypto treasury funding from Hexstone starts with a convertible preferred placement of $1 million. The note can expand to $100 million under certain conditions.

Deal terms at a glance

Investors receive preferred shares that carry special rights. The shares may include a liquidation preference and limited voting power. Typical terms set a conversion discount and a valuation cap. Maturity dates and dividend rights are also common points of negotiation.

How the convertible preferred placement works

The preferred shares convert into common stock when a trigger event happens. Triggers include a future funding round, acquisition, or a decided conversion date. Conversion often uses a discount to the next round price or a valuation cap. For example, a 20% discount lets investors buy at 80% of the new round price. Conversion reduces share percentages for existing owners, called dilution. Some deals add anti-dilution clauses to protect early investors.

Funding plan and use of proceeds

Initial proceeds will support Propanc’s PRP therapy development and build the crypto treasury. The plan may allocate funds to trials, manufacturing, and regulatory work. Part of the reserve can be held in cryptocurrencies to boost liquidity and diversification. Holding crypto brings price swings and custody risks that must be managed.

Governance and protections

Investors often get reporting rights and milestone-based protections. They may also seek seats or observer roles on the board. Clear conversion triggers and reporting help align expectations and track progress.

Crypto holdings, custody risks and progress of Propanc’s PRP therapy

Crypto treasury funds may back Propanc’s PRP therapy while adding liquidity and flexibility.

Crypto holdings and strategy

Propanc could hold Bitcoin, Ether, and stablecoins to form a reserve. Mixing assets aims to balance growth potential and downside risk. Stablecoins help cover short-term costs without exposing funds to big swings. The company may set clear rules on how much stays in crypto.

Custody risks and protections

Custody means where and how crypto assets are stored and secured. A custodian can safeguard private keys, but centralized services can be hacked. Non-custodial storage gives direct control but needs strict key backup plans. Common protections include multisig wallets, third-party audits, and insurance against theft.

Progress of Propanc’s PRP therapy

PRP therapy is still in clinical development and seeks more trial data. Early results may look promising, yet larger studies are required to confirm benefits. Funding supports trials, manufacturing scale-up, and regulatory filings that move the program forward. Using a crypto treasury can speed access to capital but adds price swings and added complexity.

Reporting and investor safeguards

Regular reporting and clear governance make crypto holdings easier to track. Milestone-based funding rounds link payments to trial progress. This approach helps align investor expectations and protect clinical work.

Fonte: Bitcoinist.com

Share This Post

Facebook
X
LinkedIn
WhatsApp
Pinterest
Reddit
Telegram
Email